Patients with metabolic liver diseases may benefit from supplements of a common gut bacterium, a small study suggests.
Excess levels of ethanol-producing Klebsiella pneumoniae strain emerge as new potential culprit for fatty liver disease
11 Nov 2019by GMFH Editing Team
Could people become drunk without touching any booze? A K. pneumoniae strain with the ability to produce alcohol endogenously has been identified as a novel culprit that may accelerate the development of non-alcoholic fatty liver disease.
Consuming probiotics is beneficial for treating metabolic diseases such as obesity, diabetes and non-alcoholic fatty liver disease, which are a global health problem.
Could increasing delivery of propionate to the human colon be a potential way of improving glucose homeostasis in overweight or obese individuals?
6 May 2019by Andreu Prados
Colonic propionate has been suggested as a potential target to improve obesity-related metabolic disorders. Based on new research, colonic propionate delivery could be a novel solution to improve metabolism and inflammation in overweight or obese subjects.
How the gut microbiota contributes to type 2 diabetes: What we already know
14 Nov 2018by Andrea Hardy
Alterations in the gut microbiota could prevent type 2 diabetes, with these changes playing a fundamental role in detecting both the condition and the onset of obesity.
Assessing the hopes, the promises and also the threats of gut microbiota research
17 Sep 2018by Cristina Sáez
Gut microbiota research has grown exponentially during the last decade, in a field of study that ranges from gut microbiota composition to the prevention or onset of diseases.
The probiotic L. rhamnosus CNCM I-3690 counteracts pathobiont-driven metabolic effects and gut barrier dysfunction in mice
30 Aug 2018by Andreu Prados
Recent research has highlighted the gut microbiome's contribution to the development of non-communicable diseases.
Meet Patrice Cani, the scientist who wants to improve your health by using a probiotic
18 Jul 2018by GMFH Editing Team
Akkermansia muciniphila, a key bacterium in stimulating the immune response and metabolic health of the host, played a leading role at the 2018 edition of the Gut Microbiota for Health World Summit.
The timing of food consumption influences the human salivary microbiota
22 Mar 2018by Andreu Prados
A recent study has found that meal timing affects the daily rhythm of the human salivary microbiota and that timing differences may have a deleterious effect on the metabolism of the host.
A brief overview of the mechanisms of action by which traditional and next-generation probiotics affect host health
19 Jan 2018by Patrice D. Cani
According to the 2014 International Scientific Association for Probiotics and Prebiotics (ISAPP) expert consensus document on the definition of probiotic, some mechanisms seem to be rare among different strains, but others are widespread among strains of the same species.